At the outset of the new year, LCGC International engaged with leading experts in the field to identify the major and ...

But in the 1990s the virus that causes AIDS turned out to offer a solution. Researchers discovered how to strip away HIV’s ...

Governor Wes Moore announced December 23, 2025, that Maryland has exceeded all targets set under the Governor’s ...

Discover the top new libraries and research facilities opening in 2026. From Delhi University's library overhaul to the V&A East Museum launch, explore the latest high-tech spaces for science, art, ...

In the current global MedTech landscape, technological breakthroughs are only the starting point. The real measure of ...

Detailed price information for Mind Medicine Mindmed Inc (MNMD-Q) from The Globe and Mail including charting and trades.

The first part of an end-of-the-year review of LCGC International’s editorial coverage of HPLC 2025, which took place in Bruges from 19–23 June 2025 .

Research presented by Dr Erik Sahai has shown that early, reversible diversity in tumour cell state can blunt the effect of ...

At ELRIG 2025 in Stevenage, AstraZeneca’s Global Leader for Flow Cytometry, Dr Raffaello Cimbro, outlined how imaging flow cytometry has evolved from a specialist tool into a cornerstone ...

AstraZeneca offers a rare, secular growth profile in biopharma, underpinned by a diversified commercial asset base and layered patent expirations. AZN faces a minor patent cliff, with most key ...

Mon, December 8, 2025 Published on Dec. 7, 2025 Published on 2025-12-07T14:04:36+07:00 rugmaker AstraZeneca plans to launch 20 new medicines by 2030, half of which will focus on treating cancer, the ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, a preclinical ...